当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析 - 现金流量表

惠泰医疗

(688617)

  

流通市值:336.77亿  总市值:336.77亿
流通股本:6686.14万   总股本:6686.14万

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金506,834,529.091,846,697,303.251,338,983,063.61900,845,620.68
收到的税费返还3,783,713.676,940,443.375,280,553.644,319,156.73
收到其他与经营活动有关的现金5,386,603.7150,888,212.8935,571,595.7415,629,960.5
经营活动现金流入的平衡项目0000
经营活动现金流入小计516,004,846.471,904,525,959.511,379,835,212.99920,794,737.91
购买商品、接受劳务支付的现金79,100,845.49330,076,464.39234,827,555.23156,525,850
支付给职工以及为职工支付的现金198,834,235.76423,414,843.35328,541,327.58225,841,474.39
支付的各项税费56,693,422.55210,866,700.17158,474,046.66104,407,274.23
支付其他与经营活动有关的现金66,788,344.61251,109,879.11173,433,404.57102,706,689.42
经营活动现金流出的平衡项目0000
经营活动现金流出小计401,416,848.411,215,467,887.02895,276,334.04589,481,288.04
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额114,587,998.06689,058,072.49484,558,878.95331,313,449.87
二、投资活动产生的现金流量:
收回投资收到的现金79,027,777.781,436,643,055.561,174,040,277.781,067,920,833.33
取得投资收益收到的现金1,080,782.8519,816,995.4412,136,189.229,149,592.35
处置固定资产、无形资产和其他长期资产收回的现金净额-12,666,911.2511,905,148.15591,044.25
投资活动现金流入的平衡项目0000
投资活动现金流入小计80,108,560.631,469,126,962.251,198,081,615.151,077,661,469.93
购建固定资产、无形资产和其他长期资产支付的现金123,402,487.66202,029,024.73136,082,730.3383,013,331.87
投资支付的现金620,432,488.78638,824,855.561,063,540,277.78626,420,833.33
取得子公司及其他营业单位支付的现金-46,372,559.1446,372,559.1446,372,559.14
投资活动现金流出的平衡项目0000
投资活动现金流出小计743,834,976.44887,226,439.431,245,995,567.25755,806,724.34
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-663,726,415.81581,900,522.82-47,913,952.1321,854,745.59
三、筹资活动产生的现金流量:
吸收投资收到的现金-34,666,234.1232,799,199.1632,799,199.16
取得借款收到的现金-70,000,00070,000,00070,000,000
筹资活动现金流入平衡项目-000
筹资活动现金流入小计-104,666,234.12102,799,199.16102,799,199.16
偿还债务支付的现金70,295,50040,273,00033,886,500591,000
分配股利、利润或偿付利息支付的现金117,650.68112,223,484.4111,865,521.61111,281,361.05
支付其他与筹资活动有关的现金2,697,397.21198,527,612.38196,006,705.22181,631,477.6
筹资活动现金流出平衡项目0000
筹资活动现金流出小计73,110,547.89351,024,096.78341,758,726.83293,503,838.65
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-73,110,547.89-246,357,862.66-238,959,527.67-190,704,639.49
四、汇率变动对现金及现金等价物的影响34,974.442,839,586.854,893,661.285,809,983.76
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-622,213,991.21,027,440,319.5202,579,060.46468,273,539.73
加:期初现金及现金等价物余额1,276,391,305.21248,950,985.71248,950,985.71248,950,985.71
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额654,177,314.011,276,391,305.21451,530,046.17717,224,525.44
补充资料:
净利润-522,130,266.64-252,634,548.67
资产减值准备-15,803,744.29--871,362.58
固定资产和投资性房地产折旧-51,584,311.99-23,236,970.53
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-51,584,311.99-23,236,970.53
无形资产摊销-4,456,177.82-1,745,080.31
长期待摊费用摊销-3,058,679.75-1,619,687.93
处置固定资产、无形资产和其他长期资产的损失--10,811,471.65--69,724.77
固定资产报废损失-123,381.56-31,475.1
公允价值变动损失----1,437,915.48
财务费用-1,026,540.64--3,166,591.45
投资损失--23,131,895.54--14,574,004.26
递延所得税--4,903,969.93--3,135,577.61
其中:递延所得税资产减少-1,906,560.73--2,885,224.78
递延所得税负债增加--6,810,530.66--250,352.83
存货的减少-11,216,999.69--1,572,225.97
经营性应收项目的减少-19,997,941.21-33,259,967.29
经营性应付项目的增加-68,902,349.08-28,378,287.68
其他-21,275,185.53-12,012,616.35
现金的期末余额-1,276,391,305.21-717,224,525.44
减:现金的期初余额-248,950,985.71-248,950,985.71
公告日期2024-04-262024-03-252023-10-272023-08-25
审计意见(境内)标准无保留意见
TOP↑